Hayat Onyuksel

Hayat Onyuksel

University of Illinois at Chicago

H-index: 39

North America-United States

About Hayat Onyuksel

Hayat Onyuksel, With an exceptional h-index of 39 and a recent h-index of 22 (since 2020), a distinguished researcher at University of Illinois at Chicago, specializes in the field of nanomedicine, drug delivery, breast cancer, rheumatoid arthritis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Thiostrepton-nanomedicine, a TLR9 inhibitor, attenuates sepsis-induced inflammation in mice

Targeting breast cancer using pirarubicin-loaded vasoactive intestinal peptide grafted sterically stabilized micelles

Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule

Targeted nanomedicines for cancer therapy, from basics to clinical trials

Hayat Onyuksel Information

University

Position

Professor of pharmaceutics and bioengineering

Citations(all)

6305

Citations(since 2020)

1544

Cited By

6129

hIndex(all)

39

hIndex(since 2020)

22

i10Index(all)

85

i10Index(since 2020)

45

Email

University Profile Page

Google Scholar

Hayat Onyuksel Skills & Research Interests

nanomedicine

drug delivery

breast cancer

rheumatoid arthritis

Top articles of Hayat Onyuksel

Thiostrepton-nanomedicine, a TLR9 inhibitor, attenuates sepsis-induced inflammation in mice

Mediators of Inflammation

2023/8/24

Targeting breast cancer using pirarubicin-loaded vasoactive intestinal peptide grafted sterically stabilized micelles

European Journal of Pharmaceutical Sciences

2021/7/1

Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule

Nanomedicine

2020/10/1

Targeted nanomedicines for cancer therapy, from basics to clinical trials

2020/5/5

See List of Professors in Hayat Onyuksel University(University of Illinois at Chicago)